TY  - GEN
AU  - Jacobs,Carmel
AU  - Ng,Terry
AU  - Ong,Michael
AU  - Clemons,Mark
TI  - Long-term benefits versus side-effects from bone-targeted therapies for cancer patients: minimizing risk while maximizing benefits
SN  - 1751-4266
PY  - 2015///0706
KW  - Antibodies, Monoclonal, Humanized
KW  - therapeutic use
KW  - Biomarkers
KW  - Bisphosphonate-Associated Osteonecrosis of the Jaw
KW  - Bone Density Conservation Agents
KW  - administration & dosage
KW  - Bone Neoplasms
KW  - drug therapy
KW  - Bone and Bones
KW  - pathology
KW  - Breast Neoplasms
KW  - Denosumab
KW  - Diphosphonates
KW  - Female
KW  - Humans
KW  - Palliative Care
KW  - Patient Selection
KW  - Quality of Life
KW  - Risk Factors
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1097/SPC.0000000000000084
ER  -